Magnesium Glycinate: What It Is, Benefits & How to Take It

Key takeaways

• Magnesium glycinate is a chelated form of magnesium bound to two glycine molecules. That chelation gives it substantially better absorption than the magnesium oxide sold in most drugstores, which Ranade & Somberg (2001) classified as having "extremely low" bioavailability.
• Both components contribute to the effect. The magnesium activates GABA receptors and quiets excitatory NMDA activity. The glycine carrier has its own independent calming and sleep-supportive properties.
• The research-backed dose range for sleep is 200-400mg elemental magnesium per day. The NIH tolerable upper limit for supplemental magnesium in adults is 350mg. Verify elemental dose on the label, not compound weight.
• Side effects at standard doses are minimal. Glycinate causes far less GI disruption than citrate or oxide forms, which is why it is the preferred form for daily long-term supplementation.
• Form and dose matter more than brand. SleepStack delivers 275mg elemental magnesium as bisglycinate, the form and dose used in clinical sleep research, with no melatonin, no blends, and nothing else.

---

What is magnesium glycinate?

Magnesium glycinate (also called magnesium bisglycinate) is formed by chelating elemental magnesium with two molecules of glycine, an amino acid. The chelation is the defining difference between glycinate and cheaper inorganic forms like magnesium oxide or magnesium carbonate.

Most magnesium supplements deliver the mineral as an inorganic salt. These forms are unstable in the digestive tract and rely almost entirely on passive paracellular absorption in the intestine, where they compete with calcium and other minerals for uptake. Ranade & Somberg (2001, PMID 11550076) classified magnesium oxide's bioavailability as "extremely low" and grouped chelated forms like glycinate among the better-absorbed salts.

Glycinate works through an additional pathway. The glycine chelation protects the magnesium ion during digestion and allows a portion to be absorbed as an intact chelate through amino acid transport channels in the proximal small intestine. This mechanism was tested directly in a 1994 randomised crossover trial by Schuette et al. (PMID 7815675), which compared 100mg doses of isotope-labelled magnesium diglycinate to magnesium oxide in 12 patients with ileal resection. Across the whole sample, absorption was statistically similar (23.5% vs 22.8%, not significant). However, in the subgroup with the most severe malabsorption, the chelate absorbed meaningfully better (23.5% vs 11.8%, p<0.05) — roughly twice the bioavailability. The chelate also reached peak absorption ~3 hours earlier than oxide.

A 2019 mouse study by Ates et al. (PMID 30761462) compared the dose-dependent tissue uptake of several magnesium compounds, including amino-acid-chelated forms (glycinate, acetyl taurate) and organic-acid-bound forms (citrate, malate). Different compounds produced distinct brain and muscle uptake patterns at varying doses, suggesting active transport mechanisms beyond simple paracellular diffusion contribute to differences between forms. As an animal study, the findings inform mechanism rather than human dosing.

The practical result: glycinate delivers more elemental magnesium to tissues per dose consumed, with substantially less GI disruption than oxide or high-dose citrate. That combination is why it has become the default form recommended for sleep and anxiety applications by practitioners who specify the form at all.

One terminology note: "magnesium glycinate" and "magnesium bisglycinate" describe the same compound. "Bisglycinate" simply confirms that two glycine molecules are attached, which is standard in commercial chelates. Both names appear interchangeably on labels and in published literature.

---

How does magnesium glycinate work in the body?

Magnesium is a cofactor in more than 300 enzymatic reactions according to the NIH Office of Dietary Supplements. It is involved in energy production, protein synthesis, DNA repair, blood glucose regulation, and the active transport of calcium and potassium ions across cell membranes. That breadth explains why deficiency manifests across a wide symptom range: muscle cramps, fatigue, elevated heart rate, poor sleep, and heightened anxiety are all documented signs of magnesium insufficiency.

Magnesium and the nervous system

The mechanism most relevant to sleep and anxiety is magnesium's relationship with GABA (gamma-aminobutyric acid), the brain's primary inhibitory neurotransmitter. Magnesium acts as a natural GABA agonist, binding to and potentiating GABA receptors (Abbasi et al., 2012, PMID 23853635), facilitating the inhibitory signal that slows neural activity, reduces heart rate, and transitions the nervous system toward rest. This is the same receptor system targeted by benzodiazepines and many pharmaceutical sleep aids, but activated through a physiological rather than pharmacological pathway.

Magnesium also acts as a natural antagonist at NMDA receptors, which are excitatory glutamate receptors (Abbasi et al., 2012, PMID 23853635). In states of magnesium deficiency, NMDA receptors are more easily activated, contributing to neural hyperexcitability, heightened stress responses, and disrupted sleep architecture. Restoring adequate magnesium levels normalises NMDA blockade, reducing the background excitation that keeps people awake.

Glycine's independent contribution

Glycine, the amino acid carrier in magnesium glycinate, is not a passive transport molecule. It functions as an inhibitory neurotransmitter in the spinal cord and brainstem. Bannai & Kawai (2012, PMID 22293292) reviewed evidence that oral glycine supplementation reduces core body temperature via peripheral vasodilation, a key physiological prerequisite for sleep onset, and improves subjective sleep quality. This dual mechanism — magnesium quieting GABA and NMDA activity in the brain while glycine contributes its own calming signal and temperature modulation — is consistent with the way users typically describe magnesium glycinate's effect: calming without the heavy sedation of melatonin or antihistamine-based sleep aids.

Absorption: how the chelation helps

The chelation allows absorption through two routes: passive paracellular transport (the standard mechanism for inorganic magnesium) and active transcellular transport via amino acid transporters. The mouse study by Ates et al. (2019, PMID 30761462) showed that different magnesium compounds produced distinct tissue-uptake patterns, supporting the idea that form matters beyond raw elemental dose. The practical effect for human supplementation is that glycinate delivers magnesium with less osmotic pull on gut fluid than oxide or citrate, which is why diarrhoea and cramping are rare at standard daily doses.

Why deficiency is common

The NIH estimates that approximately 50% of Americans consume less than the recommended daily amount of magnesium from food. Dietary magnesium is concentrated in green leafy vegetables, nuts, seeds, and whole grains: foods that are underrepresented in typical Western diets. Compounding this, several factors increase magnesium losses beyond what diet can easily replace, including alcohol, caffeine, high-sugar intake, prolonged stress (elevated cortisol increases urinary magnesium excretion), and common medications including proton pump inhibitors, diuretics, and certain antibiotics.

Many people who supplement with magnesium glycinate are correcting a pre-existing deficit. This partially explains why some users notice effects on sleep and mood within the first week: they are not adding a pharmacological agent, they are restoring a physiological baseline.

---

The research in detail

Does magnesium glycinate improve sleep?

The direct research on magnesium and sleep is most developed in older adults, who tend toward lower dietary magnesium intake and higher rates of insomnia. Abbasi et al. (2012, PMID 23853635) randomised 46 elderly subjects with primary insomnia to 500mg elemental magnesium (as oxide) or placebo for 8 weeks. The magnesium group showed significant improvements in insomnia severity (p<0.001), sleep efficiency (p=0.03), and sleep onset latency (p=0.02), with marginal improvement in early morning awakening (p=0.08). Total sleep time did not change significantly (p=0.37). Serum melatonin rose (p=0.007) and cortisol fell (p=0.008). Held et al. (2002, PMID 12163983) found similar EEG and cortisol effects in 12 healthy older adults at higher doses.

A 2025 randomised placebo-controlled trial by Schuster et al. (DOI: 10.2147/NSS.S524348) tested magnesium bisglycinate specifically — 250mg elemental in 155 adults with poor sleep over 4 weeks. The bisglycinate group showed a modest but significant ISI reduction vs placebo (p=0.049, Cohen's d=0.2), with greater response in participants who had lower baseline dietary magnesium. An ongoing trial (NCT06996171) is comparing magnesium supplementation to a melatonin congener in younger adults — a demographic underrepresented in earlier sleep research. Current dosage guidance for sleep targets 200-400mg elemental magnesium per day.

Anxiety and mood

The Boyle et al. 2017 systematic review (PMID 28445426) examined 18 intervention studies on magnesium and subjective anxiety in adults recruited for anxiety vulnerability. Results were mixed (4/8 anxious, 4/7 PMS, 1/2 hypertensive samples positive); the authors flagged the overall quality of evidence as poor and noted that no studies used a validated subjective stress measure. Sultana & Rahman (2023, NCT04880460) tested 200mg magnesium glycinate twice daily (400mg/day) as an SSRI adjunct in 90 patients with moderate-to-severe depression over 8 weeks. The magnesium arm showed significantly greater DASS-21 reduction than placebo at 8 weeks (p=0.02). Caveats: per-protocol analysis (78/90 completed), and published in EC Nutrition (ECronicon), a publisher whose journals have appeared on some predatory-publisher watchlists.

Tarleton et al. (2017, PMID 28654669) tested 248mg elemental magnesium (as chloride) for 6 weeks in adults with mild-to-moderate depression in a randomised crossover design — improvements of -6.0 points on PHQ-9 (p<0.001) and -4.5 on GAD-7 (p<0.001).

Blood pressure

NCT03688503 was a completed quadruple-masked, placebo-controlled RCT (sponsored by Brigham and Women's Hospital, with Pure Encapsulations as supplement-supplier collaborator) testing 480mg magnesium glycinate vs placebo over 12 weeks in 59 adults with elevated baseline blood pressure. The trial did not find a significant effect on either seated blood pressure (-4.5 vs -1.6 mmHg SBP from baseline; p=0.38) or 24-hour ambulatory blood pressure. Subgroup analyses suggested possibly larger effects in women and in people with SBP ≥130 mmHg, but the trial was underpowered to confirm. The NIH Health Professionals fact sheet notes that broader epidemiological and intervention data link higher magnesium intake with modestly reduced blood pressure, but the most direct test of magnesium glycinate alone for hypertension was null. The doses required for any cardiovascular effect appear to be higher than typical sleep doses.

Vitamin D activation

Dall et al. 2023 (PMID 36640582) — title: "Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control" — randomised 78 overweight/obese adults to one of three arms: vitamin D3 + 360mg magnesium glycinate, vitamin D3 alone, or placebo, for 12 weeks. The trial's primary outcomes (bone turnover markers and glycaemic indices) did not differ significantly between groups (all p>.05). As a secondary observation, serum 25-hydroxyvitamin D rose significantly more in the vitamin D + magnesium group than in the placebo group (p=.001), supporting the established role of magnesium as a co-factor for vitamin D activation. The headline takeaway: magnesium helps you absorb vitamin D, but co-supplementation didn't translate to measurable bone or glycaemic benefit at this dose and duration.

Bioavailability versus other forms

The most-cited direct comparison remains Schuette et al. 1994 (PMID 7815675), a randomised crossover in 12 patients with ileal resection. In the overall sample, magnesium diglycinate and magnesium oxide absorbed comparably (23.5% vs 22.8%, not statistically significant). In the subgroup with the most severe malabsorption, however, diglycinate absorbed roughly twice as well (23.5% vs 11.8%, p<0.05). The chelate also reached peak absorption ~3 hours earlier. The practical implication: chelation makes the largest difference in compromised absorption settings, while in healthy guts both forms can deliver similar amounts of elemental magnesium per dose.

Among well-absorbed forms, the gap between glycinate and citrate is not large. Ranade & Somberg (2001) classified both as "good" bioavailability. The practical difference is tolerability: magnesium citrate has a mild laxative effect at therapeutic doses, which limits its usefulness for the consistent daily supplementation required to build tissue magnesium levels for sleep and mood benefits. Glycinate's gentler GI profile makes sustained daily use more practical.

---

How much magnesium glycinate should I take?

Standard dosage by use case

The NIH Recommended Dietary Allowance for elemental magnesium from all sources is 400-420mg per day for adult males and 310-320mg for adult females. The tolerable upper limit for supplemental magnesium (above what you get from food) is 350mg per day for adults, the threshold above which laxative and GI effects become more likely in studies.

Most clinical research targeting sleep and anxiety uses doses of 200-400mg elemental magnesium per day from supplements. Cardiovascular research tends to use higher doses. The table below summarises the typical supplementation ranges by goal.

Reading the label correctly

Labels may express dosage as total magnesium bisglycinate (compound weight) or as elemental magnesium. These are different numbers. Magnesium bisglycinate contains approximately 11% elemental magnesium by weight: 2,500mg of bisglycinate yields roughly 275mg elemental magnesium. Always verify the elemental dose, not just the compound weight. A product listing "1,000mg magnesium glycinate" is delivering approximately 110mg elemental magnesium, not 1,000mg.

When to take it

For sleep, the most common protocol is 30-60 minutes before bed. This timing aligns with the body's natural evening shift toward parasympathetic activity and allows glycine to assist the core body temperature reduction that is a key physiological trigger for sleep onset.

For general supplementation not targeted at sleep, any consistent time of day works. Some people prefer morning to sidestep any association with drowsiness, though most users report that glycinate at standard doses does not produce the heavy sedation of melatonin or antihistamine-based sleep aids.

With or without food

Magnesium glycinate can be taken with or without food. Unlike citrate or oxide, which can cause stomach upset on an empty stomach, glycinate's gentle GI profile means food is not required. A light meal or snack alongside the supplement is fine and does not meaningfully reduce absorption.

Consistency matters more than precision

Magnesium glycinate is not an acute sleep agent in the way melatonin is. Benefits accumulate as tissue magnesium levels build over days and weeks. Most users who respond to it report improvements within one to two weeks of consistent daily use, with the full effect typically apparent by week three or four. If sleep quality has not shifted after four weeks at the correct elemental dose, magnesium insufficiency may not be a primary driver of the problem.

---

Who is magnesium glycinate for?

Magnesium glycinate is a reasonable daily supplement for adults who:

• Have difficulty falling or staying asleep, particularly when tied to stress, physical restlessness, or racing thoughts
• Experience frequent muscle cramps or nighttime leg restlessness
• Have elevated background anxiety or chronic stress without a diagnosed disorder
• Follow a Western diet low in leafy greens, nuts, seeds, and whole grains
• Supplement with vitamin D and want to ensure adequate co-factor availability for activation
• Are over 50, when dietary magnesium intake tends to decline and insomnia rates increase

Athletes and people who train at high volumes may also benefit. Exercise increases magnesium losses through sweat and urine, and magnesium is directly involved in muscle contraction, lactate clearance, and recovery.

Who should be cautious

Kidney disease. The kidneys regulate magnesium excretion. Impaired kidney function can allow supplemental magnesium to accumulate to dangerous levels. Anyone with chronic kidney disease should not take magnesium supplements without medical supervision.

Medication interactions. Magnesium can reduce the absorption of tetracycline and fluoroquinolone antibiotics and of bisphosphonates used for osteoporosis — these should be taken at least 2 hours before or 4–6 hours after a magnesium supplement. Loop and thiazide diuretics can also increase urinary magnesium loss, while potassium-sparing diuretics reduce excretion (NIH ODS Magnesium Fact Sheet for Health Professionals). Check with your pharmacist if you take any prescription medication.

High combined intake. Multiple magnesium-containing products taken at the same time, including antacids, laxatives, and supplements, can push total intake above safe levels. Check labels before stacking.

Pregnancy. Magnesium requirements increase during pregnancy. The appropriate dose and form during pregnancy should be discussed with a healthcare provider rather than self-determined.

It is also worth being direct about a limitation: magnesium glycinate does not work for everyone. Sleep has many contributing factors, including sleep apnoea, circadian disruption, chronic pain, medications, and psychological conditions that drive insomnia independently of magnesium status. If sleep problems are severe, persistent, or accompanied by symptoms beyond difficulty sleeping, speaking with a doctor is the more appropriate first step.

---

How to choose a magnesium glycinate supplement

The magnesium glycinate category ranges from well-dosed single-ingredient products to multi-ingredient "sleep blends" where glycinate appears alongside melatonin, valerian, L-theanine, and GABA in doses that make it impossible to isolate which ingredient is producing an effect. Here is what to look for.

Form on the label

Look for "magnesium glycinate" or "magnesium bisglycinate." These describe the same compound. Avoid products where magnesium oxide is the primary or only magnesium source, or where multiple forms are blended without separate elemental disclosures.

Elemental magnesium dose

Confirm the elemental magnesium dose, not just the compound weight. Anything below 150mg elemental per serving is unlikely to move the needle for sleep applications. The research-backed range for sleep is 200-400mg elemental per day.

Single ingredient vs. blends

Multi-ingredient sleep supplements are not inherently bad, but they make attribution difficult. If melatonin is included, grogginess and dependency risk are real considerations at regular doses. A single-ingredient product lets you evaluate magnesium's effect directly, which is useful before committing to a long-term regimen.

Price and dose comparison

Note that some products in this category are dosed at 120mg elemental magnesium per serving, well below the range used in sleep and anxiety research. Verify the elemental dose before purchase.

SleepStack is a single-ingredient magnesium bisglycinate at 275mg elemental per serving, within the clinical research range, with no melatonin, no hormones, and no proprietary blend. A 30-night money-back guarantee removes the financial risk for a first trial, which is a sensible starting point for anyone who wants to test magnesium glycinate without other compounds clouding the result.

---

Frequently asked questions

What does magnesium glycinate do?

Magnesium glycinate delivers elemental magnesium in a highly absorbable form, where it supports over 300 enzymatic reactions including energy production, muscle contraction, blood sugar regulation, and nervous system function. The most commonly sought effects are improved sleep quality, reduced anxiety, and relief from muscle cramps. The glycine carrier also has independent calming and sleep-supportive properties, making glycinate particularly well-suited for these goals compared to forms like oxide or citrate, which are used primarily for digestive or cardiovascular purposes.

How much magnesium glycinate should I take for sleep?

Most research on magnesium and sleep uses 200-400mg elemental magnesium per day. For adults supplementing specifically for sleep, a dose of 200-350mg elemental magnesium taken 30-60 minutes before bed is the typical protocol. The NIH tolerable upper limit for supplemental magnesium in adults is 350mg elemental per day. Always verify the elemental magnesium content on the label, as it will be lower than the total compound weight listed.

What are the side effects of magnesium glycinate?

At standard doses, magnesium glycinate is well tolerated by most healthy adults. The most common side effect is loose stools, which is significantly less likely with glycinate than with citrate or oxide due to the chelation reducing osmotic pull on gut fluid. Above 350-400mg elemental magnesium from supplements, gastrointestinal effects become more likely. Serious side effects from oral supplementation are rare in people with healthy kidney function. Those with renal impairment should consult a doctor before using any magnesium supplement.

Magnesium glycinate vs. citrate: which is better?

Both forms are well absorbed compared to magnesium oxide. Citrate is one of the most-studied forms and is commonly used to treat constipation due to its laxative effect at higher doses. Glycinate is preferred for sleep and anxiety applications because it produces far less GI disruption at the daily doses required for neurological benefits, and the glycine carrier adds its own calming properties. For consistent daily supplementation targeting sleep or stress, glycinate is the more practical choice for most people.

Is magnesium glycinate the same as magnesium bisglycinate?

Yes. Bisglycinate specifies that the magnesium is chelated with two glycine molecules, which is the standard commercial configuration. "Magnesium glycinate" is used interchangeably with "magnesium bisglycinate" on labels and in published literature. What matters is the elemental magnesium dose per serving, not which name is used.

How long does magnesium glycinate take to work for sleep?

Most people who respond to magnesium glycinate notice changes in sleep quality within one to two weeks of consistent daily use, as tissue magnesium levels build up. Some report a noticeable calming effect within the first few nights, attributed to glycine's more acute effects on body temperature and nervous system activity. The full benefit typically emerges by weeks three or four. If sleep quality has not shifted after four weeks of daily use at the correct elemental dose, magnesium deficiency may not be a primary factor in the disruption.

Can you take too much magnesium glycinate?

Yes. The NIH tolerable upper limit for supplemental magnesium is 350mg elemental per day for adults, above which loose stools, nausea, and abdominal cramping become more likely. Very high doses, typically only achievable through intravenous administration, can cause dangerously low blood pressure, irregular heartbeat, and respiratory depression. Oral supplements carry a natural safety buffer in healthy adults because the kidneys excrete excess magnesium efficiently, but this protection is significantly reduced in people with kidney disease or those taking medications that affect kidney function.

What is the best time to take magnesium glycinate?

For sleep, 30-60 minutes before bed is the standard recommendation. This timing supports the body's natural evening shift toward parasympathetic activity and gives glycine time to assist the core body temperature drop that signals sleep onset. For general daily supplementation not tied to sleep, any consistent time of day is fine. Taking it at the same time each day is more important than the specific window.

---

Sources

• Abbasi B, Kimiagar M, Sadeghniiat K, Shirazi MM, Hedayati M, Rashidkhani B. (2012). The effect of magnesium supplementation on primary insomnia in elderly: A double-blind placebo-controlled clinical trial. Journal of Research in Medical Sciences. PMID: 23853635

• Ates M, Kizildag S, Yuksel O, et al. (2019). Dose-Dependent Absorption Profile of Different Magnesium Compounds. Biological Trace Element Research 192(2):244-251. PMID: 30761462; DOI: 10.1007/s12011-019-01663-0

• Bannai M, Kawai N. (2012). New therapeutic strategy for amino acid medicine: glycine improves the quality of sleep. Journal of Pharmacological Sciences. PMID: 22293292

• Boyle NB, Lawton C, Dye L. (2017). The Effects of Magnesium Supplementation on Subjective Anxiety and Stress — A Systematic Review. Nutrients 9(5):429. PMID: 28445426; DOI: 10.3390/nu9050429

• Dall RD, Cheung MM, Shewokis PA, et al. (2023). Combined vitamin D and magnesium supplementation does not influence markers of bone turnover or glycemic control: A randomized controlled clinical trial. Nutrition Research 110:33-43. PMID: 36640582

• Held K, Antonijevic IA, Künzel H, Uhr M, Wetter TC, Golly IC, Steiger A, Murck H. (2002). Oral Mg²⁺ Supplementation Reverses Age-Related Neuroendocrine and Sleep EEG Changes in Humans. Pharmacopsychiatry 35(4):135-143. PMID: 12163983

• Ranade VV, Somberg JC. (2001). Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. American Journal of Therapeutics 8(5):345-357. PMID: 11550076

• Schuette SA, Lashner BA, Janghorbani M. (1994). Bioavailability of magnesium diglycinate vs magnesium oxide in patients with ileal resection. JPEN J Parenter Enteral Nutr 18(5):430-435. PMID: 7815675

• Schuster J, Cycelskij I, Lopresti A, Hahn A. (2025). Magnesium Bisglycinate Supplementation in Healthy Adults Reporting Poor Sleep: A Randomized, Placebo-Controlled Trial. Nature and Science of Sleep 17:2027-2040. DOI: 10.2147/NSS.S524348

• Tarleton EK, Littenberg B, MacLean CD, Kennedy AG, Daley C. (2017). Role of magnesium supplementation in the treatment of depression: A randomized clinical trial. PLOS ONE 12(6):e0180067. PMID: 28654669

• NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Health Professionals. ods.od.nih.gov/factsheets/Magnesium-HealthProfessional/

• NIH Office of Dietary Supplements. Magnesium: Fact Sheet for Consumers. ods.od.nih.gov/factsheets/Magnesium-Consumer/

• ClinicalTrials.gov. NCT03688503 — Magnesium Supplementation and Blood Pressure Reduction. clinicaltrials.gov/study/NCT03688503

• ClinicalTrials.gov. NCT04880460 — Effect of Magnesium Supplementation in SSRI Treated Major Depressive Disorder Patients. clinicaltrials.gov/study/NCT04880460

• ClinicalTrials.gov. NCT06996171 — Comparative Efficacy of Magnesium Supplement and Melatonin Congener in Young Adults With Primary Insomnia. clinicaltrials.gov/study/NCT06996171